Bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecules for redirected T-cell cytotoxicity in hematological malignancies

被引：2
|
作者：
Comeau, Michael R.
Mitchell, Danielle
Gottschalk, Rebecca
Misher, Lynda
Daugherty, Mollie
Parr, Lara
Pavlik, Peter
Woodruff, Brian
Fang, Hang
Aguilar, Megan
Bannink, Jeannette
Johnson, Starrla
Li, Gary
Miller, Robert E.
Bader, Robert
Zhang, Nicole
Sewell, Toddy
Dasovich, Maria
Hoyos, Gabriela H.
Blankenship, John W.
McMahan, Catherine
Bienvenue, David
Gross, Jane A.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-597
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
597
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
    Tianyu Cai
    Agnès Gouble
    Kathryn L. Black
    Anna Skwarska
    Ammar S. Naqvi
    Deanne Taylor
    Ming Zhao
    Qi Yuan
    Mayumi Sugita
    Qi Zhang
    Roman Galetto
    Stéphanie Filipe
    Antonio Cavazos
    Lina Han
    Vinitha Kuruvilla
    Helen Ma
    Connie Weng
    Chang-Gong Liu
    Xiuping Liu
    Sergej Konoplev
    Jun Gu
    Guilin Tang
    Xiaoping Su
    Gheath Al-Atrash
    Stefan Ciurea
    Sattva S. Neelapu
    Andrew A. Lane
    Hagop Kantarjian
    Monica L. Guzman
    Naveen Pemmaraju
    Julianne Smith
    Andrei Thomas-Tikhonenko
    Marina Konopleva
    Nature Communications, 13
  • [42] Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
    Chen, Kevin H.
    Wada, Masayuki
    Firor, Amelia E.
    Pinz, Kevin G.
    Jares, Alexander
    Liu, Hua
    Salman, Huda
    Golightly, Marc
    Lan, Fengshuo
    Jiang, Xun
    Ma, Yupo
    ONCOTARGET, 2016, 7 (35) : 56219 - 56232
  • [43] MONOCLONAL ANTI-CD44 ANTIBODY ACTS IN SYNERGY WITH ANTI-CD2 BUT INHIBITS ANTI-CD3 OR T-CELL RECEPTOR-MEDIATED SIGNALING IN MURINE T-CELL HYBRIDOMAS
    GUO, YJ
    MA, J
    WONG, JH
    LIN, SC
    CHANG, HC
    BIGBY, M
    SY, MS
    CELLULAR IMMUNOLOGY, 1993, 152 (01) : 186 - 199
  • [44] Tuning T Cell Affinity Improves Efficacy and Safety of Anti-CD38 x Anti-CD3 Bispecific Antibodies in Monkeys - a Potential Therapy for Multiple Myeloma
    Moore, Gregory L.
    Lee, Sung-Hyung
    Schubbert, Suzanne
    Miranda, Yvonne
    Rashid, Rumana
    Pong, Erik
    Phung, Sheryl
    Chan, Emily W.
    Chen, Hsing
    Endo, Nancy
    Ardila, Maria C.
    Bernett, Matthew J.
    Chu, Seung
    Leung, Irene W. L.
    Muchhal, Umesh
    Bonzon, Christine
    Szymkowski, David E.
    Desjarlais, John
    BLOOD, 2015, 126 (23)
  • [45] Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
    Cai, Tianyu
    Gouble, Agnes
    Black, Kathryn L.
    Skwarska, Anna
    Naqvi, Ammar S.
    Taylor, Deanne
    Zhao, Ming
    Yuan, Qi
    Sugita, Mayumi
    Zhang, Qi
    Galetto, Roman
    Filipe, Stephanie
    Cavazos, Antonio
    Han, Lina
    Kuruvilla, Vinitha
    Ma, Helen
    Weng, Connie
    Liu, Chang-Gong
    Liu, Xiuping
    Konoplev, Sergej
    Gu, Jun
    Tang, Guilin
    Su, Xiaoping
    Al-Atrash, Gheath
    Ciurea, Stefan
    Neelapu, Sattva S.
    Lane, Andrew A.
    Kantarjian, Hagop
    Guzman, Monica L.
    Pemmaraju, Naveen
    Smith, Julianne
    Thomas-Tikhonenko, Andrei
    Konopleva, Marina
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [46] Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas
    Martens, Anne W. J.
    Rietveld, Joanne M.
    de Boer, Renate
    Peters, Fleur S.
    Ngo, An
    van Mil, Lotte W. H. G.
    de Heer, Koen
    Spaargaren, Marcel
    Verkleij, Christie P. M.
    van de Donk, Niels W. C. J.
    Adams, Homer C.
    Eldering, Eric
    van Noesel, Carel J. M.
    Verona, Raluca
    Kater, Arnon P.
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (05): : 330 - 341
  • [47] Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins
    Holliger, P
    Manzke, O
    Span, M
    Hawkins, R
    Fleischmann, B
    Liu, QH
    Wolf, J
    Diehl, V
    Cochet, O
    Winter, G
    Bohlen, H
    CANCER RESEARCH, 1999, 59 (12) : 2909 - 2916
  • [48] DIFFERENTIAL JURKAT T-CELL ACTIVATION BY ANTI-CD3 MONOCLONAL-ANTIBODIES
    STOHL, W
    CLINICAL RESEARCH, 1989, 37 (02): : A420 - A420
  • [49] THE INDUCTION OF HUMAN T-CELL UNRESPONSIVENESS BY SOLUBLE ANTI-CD3 MAB REQUIRES T-CELL ACTIVATION
    WILLEMS, F
    ANDRIS, F
    XU, DL
    ABRAMOWICZ, D
    WISSING, M
    GOLDMAN, M
    LEO, O
    INTERNATIONAL IMMUNOLOGY, 1995, 7 (10) : 1593 - 1598
  • [50] Retargeting or Activated T Cells (ATC) with Gemtuzumab (anti-CD33) Ozogamicin x Anti-CD3 Bispecific Antibody (CD33-OBi) Enhances Cytotoxicity Directed at K562.
    Deol, Abhinav
    Thakur, Archana
    Lum, Lawrence G.
    BLOOD, 2009, 114 (22) : 1570 - 1571
12345